Company intelligence / Profile preview

AMUR Research

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

AMUR Research is a biotechnology company dedicated to combating the global threat of antimicrobial resistance (AMR). The company utilizes its proprietary AMR-X platform to discover and develop next-generation antibiotics targeting multi-drug resistant (MDR) pathogens. Their lead programs focus on high-priority threats identified by the CDC and WHO, including MRSA and carbapenem-resistant bacteria. By leveraging novel mechanisms of action, AMUR Research aims to provide effective treatments where traditional antibiotics fail. The company is headquartered in the San Francisco Bay Area and is led by experienced veterans in infectious disease drug discovery.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on AMUR Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMUR Research.

Explore the full profile